Home › Companies › MYRIAD GENETICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and MYRIAD GENETICS INC.’s Form 8-K, filed 2024-06-06 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore MYRIAD GENETICS INC. in the interactive database Compare manager voting policies
These tallies are MYRIAD GENETICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-06 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: S. Louise Phanstiel | 72,176,819 | 6,303,679 | 44,684 | -- | 5,899,075 | Majority: yes |
| Elect Director: Daniel M. Skovronsky | 77,928,386 | 557,211 | 39,585 | -- | 5,899,075 | Majority: yes |
| Proposal 2: Ratification of the Selection of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2024 | 81,454,833 | 2,917,829 | 51,595 | -- | -- | Majority: yes |
| Proposal 3: Approval, on an Advisory Basis, of the Compensation of Our Named Executive Officers, as Disclosed in the Proxy Statement | 74,410,679 | 4,060,490 | 54,013 | -- | 5,899,075 | Majority: yes |
This meeting is also recorded here as 2024-06-07; both records come from the same filing, so the date should be checked against it.
Source: MYRIAD GENETICS INC., Form 8-K, filed with the SEC on 2024-06-06 — read the filing on EDGAR.
Each item below shows how the 265 asset managers that disclosed a MYRIAD GENETICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 8 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
MYRIAD GENETICS INC.’s own tally for this item (“Proposal 3: Approval, on an Advisory Basis, of the Compensation of Our Named Executive Officers, as Disclosed in the Proxy Statement”): 74,410,679 for, 4,060,490 against, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 90,500,000 outstanding shares: 82% for, 4% against (87% of the company cast a for/against vote).
The 261 asset managers below cast 95% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,978,432 | 0 | 0 | 0 | For |
| BlackRock | 12,602,832 | 0 | 0 | 0 | For |
| State Street | 8,570,976 | 0 | 0 | 0 | For |
| Camber Capital Management LP | 7,485,000 | 0 | 0 | 0 | For |
| Wellington | 6,162,660 | 0 | 0 | 0 | For |
| EARNEST PARTNERS LLC | 3,735,094 | 0 | 0 | 0 | For |
| Artisan | 3,668,676 | 0 | 0 | 0 | For |
| GLENVIEW CAPITAL MANAGEMENT, LLC | 3,570,267 | 0 | 0 | 0 | For |
| Dimensional | 2,598,704 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,015,700 | 0 | 0 | 0 | For |
| Fidelity | 1,960,607 | 0 | 0 | 0 | For |
| Charles Schwab | 1,933,693 | 0 | 0 | 0 | For |
| DISCIPLINED GROWTH INVESTORS INC /MN | 0 | 1,724,237 | 0 | 0 | Against |
| Nuveen | 1,517,203 | 0 | 0 | 0 | For |
| TIAA | 1,456,474 | 0 | 0 | 0 | For |
| Invesco | 0 | 1,096,501 | 0 | 0 | Against |
| Northern Trust | 999,486 | 54 | 0 | 0 | For |
| DE Shaw | 940,276 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 672,063 | 0 | 0 | 0 | For |
| Citadel | 660,289 | 0 | 0 | 0 | For |
| Goldman Sachs | 632,183 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 595,244 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 465,509 | 0 | 0 | 0 | For |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 446,061 | 0 | 0 | 0 | For |
| Desjardins Global Asset Management Inc. | 0 | 368,877 | 0 | 0 | Against |
Showing the 25 largest of 261 asset managers. See all 261 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
MYRIAD GENETICS INC.’s own tally for this item (“Elect Director: Daniel M. Skovronsky”): 77,928,386 for, 557,211 against, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 90,500,000 outstanding shares: 86% for, 0.7% against (87% of the company cast a for/against vote).
The 79 asset managers below cast 99.9% of the shares they voted on this item FOR (40,028,084 for, 4,846 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,825,017 | 0 | 0 | 0 | For |
| BlackRock | 9,988,927 | 0 | 0 | 0 | For |
| State Street | 3,420,534 | 4,846 | 0 | 0 | For |
| Dimensional | 2,303,328 | 0 | 0 | 0 | For |
| Fidelity | 1,944,192 | 0 | 0 | 0 | For |
| Artisan | 1,612,034 | 0 | 0 | 0 | For |
| TIAA | 1,456,074 | 0 | 0 | 0 | For |
| Charles Schwab | 946,373 | 0 | 0 | 0 | For |
| Invesco | 531,926 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 346,931 | 0 | 0 | 0 | For |
| Goldman Sachs | 275,208 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 240,103 | 0 | 0 | 0 | For |
| Equitable | 231,983 | 0 | 0 | 0 | For |
| Jackson National | 212,044 | 0 | 0 | 0 | For |
| Global X | 181,189 | 0 | 0 | 0 | For |
| Allspring | 144,958 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 143,912 | 0 | 0 | 0 | For |
| Prudential/PGIM | 134,608 | 0 | 0 | 0 | For |
| BNY Mellon | 129,684 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 124,189 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 119,476 | 0 | 0 | 0 | For |
| Lincoln Financial | 116,399 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 116,379 | 0 | 0 | 0 | For |
| Thrivent | 114,077 | 0 | 0 | 0 | For |
| Empower | 31,041 | 0 | 0 | 0 | Not Voted |
Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.
Combines 4 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
MYRIAD GENETICS INC.’s own tally for this item (“Elect Director: S. Louise Phanstiel”): 72,176,819 for, 6,303,679 against, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 90,500,000 outstanding shares: 80% for, 7% against (87% of the company cast a for/against vote).
The 79 asset managers below cast 98% of the shares they voted on this item FOR (39,334,948 for, 697,982 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,825,017 | 0 | 0 | 0 | For |
| BlackRock | 9,988,927 | 0 | 0 | 0 | For |
| State Street | 3,411,437 | 13,943 | 0 | 0 | For |
| Dimensional | 2,303,328 | 0 | 0 | 0 | For |
| Fidelity | 1,944,192 | 0 | 0 | 0 | For |
| Artisan | 1,612,034 | 0 | 0 | 0 | For |
| TIAA | 1,456,074 | 0 | 0 | 0 | For |
| Charles Schwab | 946,373 | 0 | 0 | 0 | For |
| Invesco | 0 | 531,926 | 0 | 0 | Against |
| OLD WESTBURY FUNDS INC | 346,931 | 0 | 0 | 0 | For |
| Goldman Sachs | 275,208 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 240,103 | 0 | 0 | 0 | For |
| Equitable | 127,633 | 104,350 | 0 | 0 | For |
| Jackson National | 212,044 | 0 | 0 | 0 | For |
| Global X | 181,189 | 0 | 0 | 0 | For |
| Allspring | 144,958 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 143,912 | 0 | 0 | 0 | For |
| Prudential/PGIM | 134,608 | 0 | 0 | 0 | For |
| BNY Mellon | 129,684 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 124,189 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 119,476 | 0 | 0 | 0 | For |
| Lincoln Financial | 116,399 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 116,379 | 0 | 0 | 0 | For |
| Thrivent | 114,077 | 0 | 0 | 0 | For |
| Empower | 31,041 | 0 | 0 | 0 | Not Voted |
Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
MYRIAD GENETICS INC.’s own tally for this item (“Proposal 2: Ratification of the Selection of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2024”): 81,454,833 for, 2,917,829 against, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 90,500,000 outstanding shares: 90% for, 3% against (93% of the company cast a for/against vote).
The 79 asset managers below cast 99.8% of the shares they voted on this item FOR (39,982,070 for, 50,860 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,825,017 | 0 | 0 | 0 | For |
| BlackRock | 9,988,927 | 0 | 0 | 0 | For |
| State Street | 3,420,757 | 4,623 | 0 | 0 | For |
| Dimensional | 2,303,328 | 0 | 0 | 0 | For |
| Fidelity | 1,944,192 | 0 | 0 | 0 | For |
| Artisan | 1,612,034 | 0 | 0 | 0 | For |
| TIAA | 1,456,074 | 0 | 0 | 0 | For |
| Charles Schwab | 946,373 | 0 | 0 | 0 | For |
| Invesco | 531,926 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 346,931 | 0 | 0 | 0 | For |
| Goldman Sachs | 275,208 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 240,103 | 0 | 0 | 0 | For |
| Equitable | 231,983 | 0 | 0 | 0 | For |
| Jackson National | 212,044 | 0 | 0 | 0 | For |
| Global X | 181,189 | 0 | 0 | 0 | For |
| Allspring | 144,958 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 143,912 | 0 | 0 | 0 | For |
| Prudential/PGIM | 134,608 | 0 | 0 | 0 | For |
| BNY Mellon | 129,684 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 124,189 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 119,476 | 0 | 0 | 0 | For |
| Lincoln Financial | 116,399 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 116,379 | 0 | 0 | 0 | For |
| Thrivent | 114,077 | 0 | 0 | 0 | For |
| Empower | 31,041 | 0 | 0 | 0 | Not Voted |
Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.
Ranked by the number of MYRIAD GENETICS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 90,500,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 15.45% |
| 2 | BlackRock | 13.93% |
| 3 | State Street | 9.47% |
| 4 | Camber Capital Management LP | 8.27% |
| 5 | Wellington | 6.81% |
| 6 | EARNEST PARTNERS LLC | 4.13% |
| 7 | Artisan | 4.05% |
| 8 | GLENVIEW CAPITAL MANAGEMENT, LLC | 3.95% |
| 9 | Dimensional | 2.87% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.23% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 16.44% | 13F |
| Vanguard Group | 8.71% | 13F |
| State Street | 5.97% | 13F |
| Millennium Management | 4.74% | 13F |
| Morgan Stanley | 4.00% | 13F |
| Dimensional Fund Advisors | 2.99% | 13F |
| Goldman Sachs | 2.38% | 13F |
| Geode Capital | 2.23% | 13F |
| Nuveen | 1.58% | 13F |
Percentages above are of 90,500,000 shares outstanding, as reported by MYRIAD GENETICS INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from MYRIAD GENETICS INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At MYRIAD GENETICS INC.'s shareholder meeting held 2024-06-06, in the 2023-2024 proxy season, 265 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 1,372 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers, as… — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: MYRIAD GENETICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-06.
MYRIAD GENETICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.